Marinomed Biotech AG Announces Strategic Partnership and Worldwide Licensing for Marinosolv® Technology in Inhalation Therapy
Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding Market
Marinomed Announces Strategic Expansion into Compounding Services Featuring Marinosolv® Technology
Marinomed secures financing through successful capital increase
Public Relations